Correspondence 0001437749-22-028024 from Aravive, Inc. (CIK 0001513818)
Aravive, Inc. (CIK 0001513818)
Date: Nov. 23, 2022 · CIK: 0001513818 · Accession: 0001437749-22-028024
AI Filing Summary & Sentiment
File numbers found in text: 333-268471
Letter
arav20221123_corresp.htm
November 23, 2022
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, NE
Washington, D.C. 20549
Re:
Aravive, Inc.
Registration Statement on Form S-3
File No. 333-268471
Request For Acceleration
Ladies and Gentlemen:
Aravive, Inc. (the “Registrant”) hereby requests that the effective date of the Company’s Registration Statement on Form S-3 (File No. 333-268471), be accelerated by the U.S. Securities and Exchange Commission to Monday, November 28, 2022 at 4:00 p.m., Eastern Time, or as soon as reasonably practicable thereafter.
The Registrant understands that the Staff of the Commission will consider this request as confirmation by the Registrant that it is aware of its responsibilities under the federal securities laws as they relate to the issuance of the securities covered by the Registration Statement.
The Registrant hereby authorizes its counsel, Leslie Marlow, Esq. and Patrick J. Egan, Esq. of Blank Rome LLP, to orally modify or withdraw this request for acceleration. Please contact Ms. Marlow at (212) 885-5358 or Mr. Egan at (212) 885-5346 with any questions you may have concerning this request, and please notify either Ms. Marlow or Mr. Egan when this request for acceleration has been granted.
Very truly yours,
Aravive, Inc.
Show Raw Text
CORRESP 1 filename1.htm arav20221123_corresp.htm November 23, 2022 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, NE Washington, D.C. 20549 Re: Aravive, Inc. Registration Statement on Form S-3 File No. 333-268471 Request For Acceleration Ladies and Gentlemen: Aravive, Inc. (the “Registrant”) hereby requests that the effective date of the Company’s Registration Statement on Form S-3 (File No. 333-268471), be accelerated by the U.S. Securities and Exchange Commission to Monday, November 28, 2022 at 4:00 p.m., Eastern Time, or as soon as reasonably practicable thereafter. The Registrant understands that the Staff of the Commission will consider this request as confirmation by the Registrant that it is aware of its responsibilities under the federal securities laws as they relate to the issuance of the securities covered by the Registration Statement. The Registrant hereby authorizes its counsel, Leslie Marlow, Esq. and Patrick J. Egan, Esq. of Blank Rome LLP, to orally modify or withdraw this request for acceleration. Please contact Ms. Marlow at (212) 885-5358 or Mr. Egan at (212) 885-5346 with any questions you may have concerning this request, and please notify either Ms. Marlow or Mr. Egan when this request for acceleration has been granted. Very truly yours, Aravive, Inc. By: /s/ Gail McIntyre Name: Gail McIntyre Title: Chief Executive Officer cc: Leslie Marlow, Esq., Blank Rome LLP Patrick J. Egan, Esq., Blank Rome LLP